| 103.13 Data as of May 24 |  -0.27 / -0.26%Today’s Change | 73.64 Today|||52-Week Range 105.66 | +23.49% Year-to-Date |
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
| 1 month | +3.66% | 3 years | +22.22% | |
| 3 months | +13.93% | 5 years | +12.07% | |
| 1 year | +37.66% | Since inception | +5.49% |
| Previous close | $103.40 |
| Open day’s range | 102.40 – 103.23 |
| Net asset value (NAV) | 103.10 (05/24/2013) |
| Daily volume | 24,476 |
| Average volume (3 months) | 83,474 |
| IYH | Category | |
|---|---|---|
| Performance 5-yr return | +12.07% | +13.03% |
| Expense Gross exp ratio | 0.47% | 0.47% |
| Risk 5 year sharpe ratio | 0.74 | 0.75 |
| Net assets | $986.1M | $776.1M |
| Average market cap | $47.9B | $19.4B |
| Average P/E | 19.8 | 21.6 |
| Dividend / Share | -- | 0.22% |
| VHT Vanguard Health Care ETF |
| XLV Health Care Select Sector SPDR Fund |
| IXJ iShares S&P Global Healthcare Index Fund |
| Healthcare | 99.73% |
| Hardware | 0.15% |
| Business service | 0.12% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| JNJ Johnson & Johnson | 12.17% |
| PFE Pfizer Inc | 10.68% |
| MRK Merck & Co Inc | 7.26% |
| AMGN Amgen Inc | 3.98% |
| GILD Gilead Sciences Inc | 3.94% |
| ABBV AbbVie Inc | 3.72% |
| BMY Bristol-Myers Squibb Company | 3.32% |
| UNH UnitedHealth Group Inc | 3.14% |
| ABT Abbott Laboratories | 2.96% |
| LLY Eli Lilly and Company | 2.82% |
.
